Newamsterdam Pharma Corporation Is A Clinical Stage Biopharmaceutical Company Based In Naardennetherlandsfounded In 2020The Company Specializes In Developing Oral Therapies For Cardiometabolic Diseaseswith A Strong Emphasis On Cardiovascular Diseasecvd Newamsterdam Is Publicly Traded On Nasdaq Under The Ticker Nams And Aims To Address Unmet Patient Needs In Lipid Management And Cvd Prevention The Company S Core Productobicetrapibis A Once Daily Cetp Inhibitor Designed To Lower Ldl C Levels In High Risk Cvd Patientsit Is Currently Undergoing Phase 3 Trials To Validate Its Effectiveness As A Monotherapy And In Combination With Ezetimibenewamsterdam Has Established Strategic Partnershipsincluding A Licensing Agreement With Menarini Group For The European Commercialization Of Obicetrapibthe Company Is Committed To Advancing Cvd Treatment And Reducing Mortality Through Patient Centric Drug Development
No conferences found for this company.
| Company Name | Newamsterdam Pharma Co Nv |
| Country |
Netherlands
|
| Address | Gooimeer 2 35 1411 Dc Naarden Netherlands |
| Telephone | Login to View |
| Login to View |
